SARS-CoV-2 Host interactomics based gene-drug signatures

Published: 6 July 2020| Version 1 | DOI: 10.17632/v6pymtdyck.1
Contributor:
George Vavougios

Description

Gene-Drug signatures derived from interactome analysis of two published SARS-CoV-2 infection induced gene signatures.

Files

Steps to reproduce

Gene-Drug signatures derived from interactome analysis of two published SARS-CoV-2 infection induced gene signatures.

Categories

Antiviral Drug, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19

Licence